US-based researchers have developed a Magnetic Resonance Imaging (MRI) technology that can determine whether a cancerous tumour is benign or malignant without performing a biopsy. Biopsies are invasive procedures to sample tumour cells and are not risk-free, researchers noted. The new technology uses the MRI scans to painlessly detect stage 1 kidney tumours with 80% accuracy.